BackObsEva SA. Overview

ObsEva SA. Gross Profit

Track ObsEva SA.'s gross profit ($20M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Gross Profit

$19.64M

As of Dec 31, 2022

Annual Gross Profit (TTM)

$19.64M

Trailing 12 months ending Dec 31, 2022

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

ObsEva SA. (OBSV) FAQ

The latest gross profit for OBSV is $20M as of December 2022. In the prior-year period, the figure was $0. That is below the Healthcare sector average of $66B. Investors often review this figure alongside ObsEva SA.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, OBSV's gross profit moved from $0 to $20M. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in ObsEva SA.'s operating scale or balance-sheet position.

Against Healthcare companies, OBSV currently prints $20M for gross profit, while the sector average sits near $66B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at ObsEva SA.'s growth, margins, and balance sheet.

A gross profit figure of $20M for OBSV is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $66B. Explore the charts below for those layers of context.

After noting OBSV's gross profit ($20M), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.